SUPPLEMENTAL AGREEMENTSupplemental Agreement • November 18th, 2004 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledNovember 18th, 2004 Company Industry JurisdictionThis Supplemental Agreement (this “Supplemental Agreement”), dated as of March 15 2002, is made and entered into by and among Inhale Therapeutic Systems, Inc. (“Inhale”) and Alliance Pharmaceutical Corporation (“Alliance”) (collectively referred to as the “Parties”).